Lawrence P. Guiheen's most recent trade in Adma Biologics Inc was a trade of 20,000 Common Stock done at an average price of $21.0 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Sale of securities on an exchange or to another person at price $ 20.96 per share. | 09 Jun 2025 | 20,000 | 94,830 (0%) | 0% | 21.0 | 419,200 | Common Stock |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.96 per share. | 21 May 2025 | 7,779 | 122,609 (0%) | 0% | 6.0 | 46,363 | Common Stock |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 7,779 | 1,221 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 21 May 2025 | 7,779 | 114,830 (0%) | 0% | 20.3 | 158,069 | Common Stock |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,221 | 0 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Sale of securities on an exchange or to another person at price $ 20.12 per share. | 21 May 2025 | 1,221 | 114,830 (0%) | 0% | 20.1 | 24,567 | Common Stock |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.96 per share. | 21 May 2025 | 1,221 | 116,051 (0%) | 0% | 6.0 | 7,277 | Common Stock |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 16,279 | 16,279 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 10,889 | 164,830 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 09 Sep 2024 | 9,000 | 153,941 (0%) | 0% | 18.5 | 166,189 | Common Stock |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 9,000 | 0 | - | - | Common Stock | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.80 per share. | 09 Sep 2024 | 9,000 | 162,941 (0%) | 0% | 10.8 | 97,200 | Common Stock |
| Adma Biologics Inc | P. Guiheen Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 37,541 | 37,541 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | P. Guiheen Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 24,040 | 153,941 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 51,630 | 51,630 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 25,815 | 129,901 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 53,172 | 53,172 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 26,586 | 104,086 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Lawrence P. Guiheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 55,000 | 55,000 | - | - | Stock Option (right to buy) |